Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Hanahan

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
Journal for Immunotherapy of Cancer|May 8, 2019
Carboplatin/paclitaxel, E7-vaccination and intravaginal CpG as tri-therapy towards efficient regression of genital HPV16 tumorsSonia Domingos-Pereira, Gabriele Galliverti, Douglas Hanahan, et al.
Plos One|February 12, 2009
Genetic ablation of Bcl-x attenuates invasiveness without affecting apoptosis or tumor growth in a mouse model of pancreatic neuroendocrine cancerJeffrey H Hager, Danielle B Ulanet, Lothar Hennighausen, et al.
Blood|July 23, 2011
Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expressionMarcela Franco, Pernilla Roswall, Eliane Cortez, et al.
Cell Reports|October 26, 2018
Pan-Cancer Landscape of Aberrant DNA Methylation across Human TumorsSadegh Saghafinia, Marco Mina, Nicolo Riggi, et al.
Cancer Cell|February 9, 2010
Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent MannerNeta Erez, Morgan Truitt, Peter Olson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 12, 2010
Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapyDanielle B Ulanet, Dale L Ludwig, C Ronald Kahn, et al.
Plos Biology|October 19, 2007
Assessing tumor progression factors by somatic gene transfer into a mouse model: Bcl-xL promotes islet tumor cell invasionYi-Chieh Nancy Du, Brian C Lewis, Douglas Hanahan, et al.
The Journal of Clinical Investigation|May 3, 2003
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitorsGabriele Bergers, Steven Song, Nicole Meyer-Morse, et al.
Oncogene|July 12, 2005
Incomplete inhibition of the Rb tumor suppressor pathway in the context of inactivated p53 is sufficient for pancreatic islet tumorigenesisOriol Casanovas, Jeffrey H Hager, Matthew Gee Hong Chun, et al.
Cancer Research|June 3, 2006
Lymphatic zip codes in premalignant lesions and tumorsLianglin Zhang, Enrico Giraudo, Jason A Hoffman, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Journal for Immunotherapy of Cancer|May 8, 2019
Carboplatin/paclitaxel, E7-vaccination and intravaginal CpG as tri-therapy towards efficient regression of genital HPV16 tumorsSonia Domingos-Pereira, Gabriele Galliverti, Douglas Hanahan, et al.
Plos One|February 12, 2009
Genetic ablation of Bcl-x attenuates invasiveness without affecting apoptosis or tumor growth in a mouse model of pancreatic neuroendocrine cancerJeffrey H Hager, Danielle B Ulanet, Lothar Hennighausen, et al.
Blood|July 23, 2011
Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expressionMarcela Franco, Pernilla Roswall, Eliane Cortez, et al.
Cell Reports|October 26, 2018
Pan-Cancer Landscape of Aberrant DNA Methylation across Human TumorsSadegh Saghafinia, Marco Mina, Nicolo Riggi, et al.
Cancer Cell|February 9, 2010
Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent MannerNeta Erez, Morgan Truitt, Peter Olson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 12, 2010
Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapyDanielle B Ulanet, Dale L Ludwig, C Ronald Kahn, et al.
Plos Biology|October 19, 2007
Assessing tumor progression factors by somatic gene transfer into a mouse model: Bcl-xL promotes islet tumor cell invasionYi-Chieh Nancy Du, Brian C Lewis, Douglas Hanahan, et al.
The Journal of Clinical Investigation|May 3, 2003
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitorsGabriele Bergers, Steven Song, Nicole Meyer-Morse, et al.
Oncogene|July 12, 2005
Incomplete inhibition of the Rb tumor suppressor pathway in the context of inactivated p53 is sufficient for pancreatic islet tumorigenesisOriol Casanovas, Jeffrey H Hager, Matthew Gee Hong Chun, et al.
Cancer Research|June 3, 2006
Lymphatic zip codes in premalignant lesions and tumorsLianglin Zhang, Enrico Giraudo, Jason A Hoffman, et al.
Pageof 11